Repository logo
 
Publication

Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes

dc.contributor.authorPires, Vanessa Borges
dc.contributor.authorSimões, Ricardo
dc.contributor.authorMamchaoui, Kamel
dc.contributor.authorCarvalho, Célia
dc.contributor.authorCarmo-Fonseca, Maria
dc.date.accessioned2021-12-03T15:36:08Z
dc.date.available2021-12-03T15:36:08Z
dc.date.issued2017
dc.descriptionCopyright: © 2017 Pires et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.pt_PT
dc.description.abstractSplice-switching antisense oligonucleotides (SSOs) offer great potential for RNA-targeting therapies, and two SSO drugs have been recently approved for treating Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA). Despite promising results, new developments are still needed for more efficient chemistries and delivery systems. Locked nucleic acid (LNA) is a chemically modified nucleic acid that presents several attractive properties, such as high melting temperature when bound to RNA, potent biological activity, high stability and low toxicity in vivo. Here, we designed a series of LNA-based SSOs complementary to two sequences of the human dystrophin exon 51 that are most evolutionary conserved and evaluated their ability to induce exon skipping upon transfection into myoblasts derived from a DMD patient. We show that 16-mers with 60% of LNA modification efficiently induce exon skipping and restore synthesis of a truncated dystrophin isoform that localizes to the plasma membrane of patient-derived myotubes differentiated in culture. In sum, this study underscores the value of short LNA-modified SSOs for therapeutic applications.pt_PT
dc.description.sponsorshipThis work was supported by Fundação para a Ciência e Tecnologia, Portugal (FCT-ANR/BIM-ONC/0009/2013), http://www.fct.pt/; Faculdade de Medicina da Universidade de Lisboa, Gabinete de Apoio à Investigação Científica, Tecnológica e Inovação, Portugal (GAPIC 2012009 GAPIC 20130041 (RS)), http://www.medicina.ulisboa.pt/investigacao/gapic/.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationPloS one, 12(7), e0181065.pt_PT
dc.identifier.doi10.1371/journal.pone.0181065pt_PT
dc.identifier.eissn1932-6203
dc.identifier.urihttp://hdl.handle.net/10451/50269
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherPLOSpt_PT
dc.relationEpigenetics and alternative splicing: role in immune T cell differentiation and leukemogenesis
dc.relation.publisherversionjournals.plos.org/plosone/pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.titleShort (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubespt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleEpigenetics and alternative splicing: role in immune T cell differentiation and leukemogenesis
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/FCT-ANR%2FBIM-ONC%2F0009%2F2013/PT
oaire.citation.issue7pt_PT
oaire.citation.startPagee0181065pt_PT
oaire.citation.titlePLOS ONEpt_PT
oaire.citation.volume12pt_PT
oaire.fundingStream3599-PPCDT
person.familyNameCarvalho
person.familyNameCarmo-Fonseca
person.givenNameCélia
person.givenNameMaria
person.identifier.ciencia-idDD18-667D-59FE
person.identifier.ciencia-idB31F-0435-0753
person.identifier.orcid0000-0002-5980-595X
person.identifier.orcid0000-0002-3402-7143
person.identifier.scopus-author-id7007128195
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication0bc60872-4f9a-44d0-9bd6-13c82c3298c2
relation.isAuthorOfPublicationf4cae50c-2389-4b6a-8e3a-8fd8e538add0
relation.isAuthorOfPublication.latestForDiscovery0bc60872-4f9a-44d0-9bd6-13c82c3298c2
relation.isProjectOfPublication823932d7-c992-457a-8462-923835595d3c
relation.isProjectOfPublication.latestForDiscovery823932d7-c992-457a-8462-923835595d3c

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Short_16mer.pdf
Size:
8.74 MB
Format:
Adobe Portable Document Format